Search hospitals
>
Washington
>
Kennewick
Kadlec Clinic Hematology and Oncology
Claim this profile
Kennewick, Washington 99336
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Lymphoma
327 reported clinical trials
9 medical researchers
Summary
Kadlec Clinic Hematology and Oncology is a medical facility located in Kennewick, Washington. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Lymphoma and other specialties. Kadlec Clinic Hematology and Oncology is involved with conducting 327 clinical trials across 457 conditions. There are 9 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.
Area of expertise
Breast Cancer
Kadlec Clinic Hematology and Oncology has run 67 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Kadlec Clinic Hematology and Oncology has run 56 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Alison K. Conlin
Providence Portland Medical Center
7 years of reported clinical research
Charles W. Drescher
Providence Portland Medical Center
9 years of reported clinical research
Nitya Alluri
Providence Portland Medical Center
2 years of reported clinical research
Krishna C. Alluri
Providence Portland Medical Center
6 years of reported clinical research
Clinical Trials running at Kadlec Clinic Hematology and Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Ovarian Cancer
Breast cancer
Esophageal cancer
Multiple Myeloma
Bladder Carcinoma
Colorectal Cancer
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting
2 awards
Phase 3
8 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting
2 awards
Phase 3
47 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kadlec Clinic Hematology and Oncology?
Kadlec Clinic Hematology and Oncology is a medical facility located in Kennewick, Washington. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Lymphoma and other specialties. Kadlec Clinic Hematology and Oncology is involved with conducting 327 clinical trials across 457 conditions. There are 9 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.
Where is Kadlec Clinic Hematology and Oncology located?
The Kadlec Clinic Hematology and Oncology is located at 7360 W Deschutes Ave, Kennewick, WA 99336.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Kadlec Clinic Hematology and Oncology, patients or guarantors can obtain a free Financial Assistance Application directly from Kadlec, by mail, or by downloading it from www.kadlec.org. Completed applications, along with required documentation, should be submitted as instructed. Additionally, patients can manage their medical bills, including viewing and secure online payment, through the Kadlec Regional Medical Center website.
What insurance does Kadlec Clinic Hematology and Oncology accept?
Kadlec Clinic Hematology and Oncology accepts a variety of insurance plans, including but not limited to Aetna Choice POS II, Aetna Managed Choice POS Open Access, and Aetna Signature Administrators PPO. The clinic specializes in diagnosing and treating blood diseases and cancer, offering services such as advanced diagnostic imaging, chemotherapy, and genetic counseling, alongside support services like oncology dietitian/nutrition counseling and survivorship programs. It has been awarded a three-year accreditation with commendation by the American College of Surgeons Commission on Cancer, highlighting its commitment to providing care that meets the highest standards.
What awards or recognition has Kadlec Clinic Hematology and Oncology received?
Kadlec Clinic Hematology and Oncology, located in Kennewick, Washington, is renowned for its exceptional cancer care, boasting five national cancer accreditations. It has also been awarded a three-year accreditation with commendation by the American College of Surgeons Commission on Cancer, affirming its commitment to providing care that adheres to the highest standards.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.